Therefore, understanding the mechanisms controlling DANCR expression during breast cancer development, effectively targeting these mechanisms, and developing strategies to either suppress DANCR or up‐regulate SOCS3 may prevent tumorigenesis and suppress the malignant progression of breast cancer. Here, DANCR is linked to breast carcinoma.